HDR endobronchial brachytherapy (HDRBT) in the management of advanced lung cancer - Comparison of two different dose schedules

Radiotherapy and Oncology

Volumn 93, Issue 3, 2009, Pages 436-440

  Skowronek, Janusz ^a   Kubaszewska, Magda ^a   Kanikowski, Marek ^a   Chicheł, Adam ^a   Młynarczyk, Witold ^a,b  

^a GREATER POLAND CANCER CENTRE   (Poland)

^b Pneumonology Clinic   (Poland)

Author keywords

Brachytherapy; Fractional dose; Lung cancer; Radiotherapy

Indexed keywords

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DYSPNEA; FEMALE; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE;

AGED; BRACHYTHERAPY; BRONCHI; BRONCHIAL DISEASES; BRONCHOCONSTRICTION; CONSTRICTION, PATHOLOGIC; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 70449675071     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.09.005     Document Type: Article

References (26)

1. Barber P., and Stout R. High dose rate endobronchial brachytherapy for the treatment of lung cancer: current status and indications. Thorax 51 (1996) 345-347
2. Delclos M.E., Komaki R., Morice R.C., et al. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions. Radiology 201 (1996) 279-382
3. Stephens Jr. K.E., and Wood D.E. Bronchoscopic management of central airway obstruction. J Thorac Cardiovasc Surg 119 (2000) 289-296
4. Sutedja G., Baris G., van Zadwijk N., et al. High-dose rate brachytherapy has a curative potential in patients with intraluminal squamous cell lung cancer. Respiration 61 (1993) 167-168
5. Taulelle M., Chauvet B., Vincent P., et al. High dose rate endobronchial brachytherapy: results and complications in 189 patients. Eur Respir J 11 (1998) 162-168
6. Skowronek J., Piotrowski T., Ramlau R., Cofta Sz., Świerkocki K., Piorunek T., and Młynarczyk In. The repeated use of high dose rate brachytherapy to palliate symptomatic recurrence of lung cancer. Rep Pract Radioth Oncol 4 (2003) 127-137
7. Harms W., Schraube P., Becker H., et al. Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumors of the upper respiratory tract. Strahlenther Onkol 176 (2000) 60-66
8. Hilaris B.S., and Mastoras D.A. Contemporary brachytherapy approaches in non- small cell lung cancer. J Surg Oncol 69 (1998) 258-264
9. Perol M., Caliandro R., Pommier P., et al. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study. Chest 111 (1997) 1417-1423
10. Macha H.N., and Freitag L. The role of brachytherapy in the treatment and control of central bronchial carcinoma. Monaldi Arch Chest Dis 51 (1996) 325-328
11. Skowronek J., Piotrowski T., Młynarczyk W., and Ramlau R. Advanced tracheal carcinoma - a therapeutic significance of HDR brachytherapy in palliative treatment. Neoplasma 51 4 (2004) 313-318
12. Speiser B.L., and Spratling L. Remote afterloading brachytherapy for the local control of endobronchial carcinoma. Int J Radiat Oncol Biol Phys 25 (1993) 579-587
13. Gaspar L.E. Brachytherapy in lung cancer. J Surg Oncol 67 (1998) 60-70
14. Makarewicz R., Czechowicz W., and Terlikiewicz J. Wste{ogonek}pna ocena skuteczności paliatywnej brachyterapii u chorych na niedrobnokomórkowego raka płuca. Nowotwory 45 (1995) 260-265 [in Polish]
15. Speiser B.L. Brachytherapy in the treatment of thoracic tumors Lung and esophageal. Hematol Oncol Clin North Am 13 (1999) 609-634
16. Kasprowicz A., Łyczek J., Kulik A., et al. Paliatywna jednofrakcyjna brachyterapia HDR w leczeniu zaawansowanego miejscowo raka oskrzeli. Nowotwory 49 (1999) 35-38 [in Polish]
17. Kubaszewska M., Skowronek J., Chicheł A., and Kanikowski M. The use of high dose rate endobrachial brachytherapy to palliate symptomatic recurrence of previously irradiated lung cancer. Neoplasma 3 (2008) 239-245
18. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
19. Dosoretz D.E., Katin M.J., Blitzer P.H., et al. Medically inoperable lung carcinoma: the role of radiation therapy. Semin Radiat Oncol 6 (1996) 98-104
20. Langendijk H., de Jong J., Tjwa M., et al. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiother Oncol 58 (2001) 257-268
21. Kelly J.F., Delclos M.E., Morice R.C., et al. High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-years M.D. Anderson cancer center experience. Int J Radiat Oncol Biol Phys 48 (2000) 697-702
22. Gustafson G., Vincini F., Freedman L., et al. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies. Cancer 75 (1995) 2345-2350
23. Nori D., Allison R., and Kaplan B. High dose rate intraluminal irradiation in bronchogenic carcinoma. Chest 104 (1993) 1006-1011
24. Bedwinek J., Petty A., and Bruton C. The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 22 (1991) 23-30
25. Huber R.M., Fisher R., Hautmann H., et al. Palliative endobronchial brachytherapy for central lung tumors. A prospective, randomized comparison of two fractionation schedules. Chest 107 (1995) 463-470
26. Gollins S.W., Ryder W.D.J., and Burt P.V. Massive haemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus. Radiother Oncol 39 (1996) 105-116